Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Sees Large Growth in Short Interest

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) saw a large growth in short interest during the month of July. As of July 15th, there was short interest totaling 81,981 shares, a growth of 320.4% from the June 30th total of 19,501 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.

Shin Nippon Biomedical Laboratories Stock Performance

Shares of OTCMKTS SBLOF opened at $7.00 on Tuesday. The stock’s fifty day simple moving average is $7.65 and its 200 day simple moving average is $8.98. Shin Nippon Biomedical Laboratories has a 52-week low of $7.00 and a 52-week high of $9.16.

Shin Nippon Biomedical Laboratories Company Profile

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.

The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.